Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002778434 | SCV003591433 | uncertain significance | Inborn genetic diseases | 2021-12-16 | criteria provided, single submitter | clinical testing | The c.572A>G (p.K191R) alteration is located in exon 4 (coding exon 4) of the KMT2C gene. This alteration results from a A to G substitution at nucleotide position 572, causing the lysine (K) at amino acid position 191 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV005059275 | SCV005722724 | likely benign | not provided | 2024-03-11 | criteria provided, single submitter | clinical testing |